SG49111A1 - 7-(2-Imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists - Google Patents

7-(2-Imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists

Info

Publication number
SG49111A1
SG49111A1 SG1996006085A SG1996006085A SG49111A1 SG 49111 A1 SG49111 A1 SG 49111A1 SG 1996006085 A SG1996006085 A SG 1996006085A SG 1996006085 A SG1996006085 A SG 1996006085A SG 49111 A1 SG49111 A1 SG 49111A1
Authority
SG
Singapore
Prior art keywords
unsubstituted
imidazolinylamino
alpha
subject invention
compounds useful
Prior art date
Application number
SG1996006085A
Other languages
English (en)
Inventor
Thomas Lee Cupps
Sophie Eva Bogdan
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of SG49111A1 publication Critical patent/SG49111A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SG1996006085A 1993-12-17 1994-12-15 7-(2-Imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists SG49111A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16934293A 1993-12-17 1993-12-17
US08/292,672 US5576437A (en) 1993-12-17 1994-08-18 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists

Publications (1)

Publication Number Publication Date
SG49111A1 true SG49111A1 (en) 1998-05-18

Family

ID=26864973

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996006085A SG49111A1 (en) 1993-12-17 1994-12-15 7-(2-Imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists

Country Status (23)

Country Link
US (2) US5576437A (ja)
EP (1) EP0734261B1 (ja)
JP (1) JPH09507219A (ja)
CN (1) CN1085945C (ja)
AT (1) ATE202475T1 (ja)
AU (1) AU704857B2 (ja)
BR (1) BR9408344A (ja)
CA (1) CA2179011C (ja)
CZ (1) CZ285990B6 (ja)
DE (1) DE69427591T2 (ja)
DK (1) DK0734261T3 (ja)
ES (1) ES2158076T3 (ja)
FI (1) FI962492A (ja)
GR (1) GR3036199T3 (ja)
HU (1) HU219494B (ja)
NO (1) NO311749B1 (ja)
NZ (1) NZ333369A (ja)
PE (1) PE38095A1 (ja)
PL (1) PL178054B1 (ja)
SG (1) SG49111A1 (ja)
SK (1) SK77296A3 (ja)
TW (1) TW406077B (ja)
WO (1) WO1995020386A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6172095B1 (en) 1996-11-25 2001-01-09 The Procter & Gamble Company Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
US6306877B1 (en) 1999-08-09 2001-10-23 The Procter & Gamble Co. Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
IL130023A0 (en) * 1996-11-25 2000-02-29 Procter & Gamble Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
TW527355B (en) 1997-07-02 2003-04-11 Bristol Myers Squibb Co Inhibitors of farnesyl protein transferase
US6572858B1 (en) * 1999-04-30 2003-06-03 Apt Pharmaceuticals, Llc Uses for anti-malarial therapeutic agents
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JP2007538004A (ja) * 2004-03-18 2007-12-27 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド シヌクレイノパチーを治療する方法
WO2005089515A2 (en) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
US20070293539A1 (en) * 2004-03-18 2007-12-20 Lansbury Peter T Methods for the treatment of synucleinopathies
CA2559285A1 (en) * 2004-03-18 2005-09-29 Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
CA2559282A1 (en) * 2004-03-18 2005-09-29 Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
DE102004049008A1 (de) * 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
NZ568694A (en) 2005-11-09 2011-09-30 Zalicus Inc Method, compositions, and kits for the treatment of medical conditions
US8232402B2 (en) * 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
US20100331363A1 (en) * 2008-11-13 2010-12-30 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
US20110060005A1 (en) * 2008-11-13 2011-03-10 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
BRPI0920927A2 (pt) * 2008-11-13 2019-09-24 Link Medicine Corp derivados de azaquinolinona e usos dos mesmos
CA2843251A1 (en) * 2011-07-25 2013-01-31 Santosh C. Sinha N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US4029792A (en) * 1972-02-29 1977-06-14 Pfizer Inc. (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents
US4036976A (en) * 1973-04-05 1977-07-19 Sandoz, Inc. Substituted imidazolinylamino-indazoles
US4217356A (en) * 1975-08-22 1980-08-12 Sandoz Ltd. 2-Imidazolinylamino-2,1,3-benzothiadiazoles
US4398028A (en) * 1977-01-14 1983-08-09 Sandoz Ltd. Bicyclic heterocyclic amino derivatives
EP0025269B1 (en) * 1979-08-23 1985-11-13 Beecham Group Plc Anti-diarrhoea veterinary composition
US4436913A (en) * 1980-09-05 1984-03-13 Siegfried Aktiengesellschaft 1H- and 2H- indazole derivatives
FR2638356A1 (fr) * 1988-10-28 1990-05-04 Anben Nouveaux derives de la 2-arylimino-imidazolidine pour diminuer la pression intra-oculaire et traiter le glaucome
US5180721A (en) * 1989-05-22 1993-01-19 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5281591A (en) * 1989-05-22 1994-01-25 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5231096A (en) * 1989-10-12 1993-07-27 Allergan, Inc. Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
US5021416A (en) * 1989-10-31 1991-06-04 Allergan, Inc. Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents

Also Published As

Publication number Publication date
US5576437A (en) 1996-11-19
BR9408344A (pt) 1997-08-19
PL315058A1 (en) 1996-09-30
FI962492A (fi) 1996-07-25
NO311749B1 (no) 2002-01-21
FI962492A0 (fi) 1996-06-14
HU9601661D0 (en) 1996-08-28
JPH09507219A (ja) 1997-07-22
PL178054B1 (pl) 2000-02-29
EP0734261B1 (en) 2001-06-27
NO962537D0 (no) 1996-06-14
PE38095A1 (es) 1995-11-28
HUT76278A (en) 1997-07-28
CA2179011C (en) 1999-11-30
DE69427591D1 (de) 2001-08-02
WO1995020386A1 (en) 1995-08-03
NO962537L (no) 1996-08-14
AU1339495A (en) 1995-08-15
CN1085945C (zh) 2002-06-05
ATE202475T1 (de) 2001-07-15
EP0734261A1 (en) 1996-10-02
NZ333369A (en) 2001-04-27
HU219494B (hu) 2001-04-28
CA2179011A1 (en) 1995-08-03
DK0734261T3 (da) 2001-09-03
SK77296A3 (en) 1997-04-09
ES2158076T3 (es) 2001-09-01
GR3036199T3 (en) 2001-10-31
CZ285990B6 (cs) 1999-12-15
CN1137754A (zh) 1996-12-11
US5716966A (en) 1998-02-10
DE69427591T2 (de) 2002-04-25
AU704857B2 (en) 1999-05-06
CZ175296A3 (en) 1996-11-13
TW406077B (en) 2000-09-21

Similar Documents

Publication Publication Date Title
SG44628A1 (en) 6-(2-imidazolinylamino) Quinoxaline compounds useful as alpha-2 adrenoceptor agonists
HU9601661D0 (en) 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
SG49049A1 (en) 5-(-2-Imidazolinylamino) benzimidazole derivatives their preparation and their use as alpha-2 adrenoceptor agonists
DK1137762T3 (da) Behandling af Pompes sygdom
SG55141A1 (en) 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists